{"success":true,"data":{"pressRelease":{"id":"62246","rtpr_id":"nACSRndsNa","ticker":"ADMA","exchange":"NASDAQ","all_tickers":["ADMA"],"title":" ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","published_at":"2026-06-12T11:00:06.446Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n12, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of its officers.\n(https://app.accessnewswire.com/imagelibrary/3a0d22a5-d2a9-48e7-9ee7-69e3d4693895/image.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired ADMA securities between August\n9, 2024 and March 25, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/ADMA.\n(https://bgandg.com/ADMA/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=ADMA)\n\nADMA Case Details\n\nThe Complaint alleges that throughout the Class Period, Defendants made false\nand/or misleading statements and/or failed to disclose that:\n1.\nADMA Biologics engaged in an undisclosed related party transaction;\n2.\nADMA Biologics used channel stuffing to create an appearance of revenue;\n3.\nADMA Biologics lacked adequate internal controls; and\n4.\nas a result, defendants' statements about ADMA Biologics' business,\noperations, and prospects were materially false and misleading and/or lacked a\nreasonable basis at all relevant times.\n\nWhat's Next for ADMA Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/ADMA.\n(https://bgandg.com/ADMA/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=ADMA)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in ADMA you have until August 10,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to ADMA Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for ADMA Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/adma-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1176125)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSRndsNa","title":" ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","ticker":"ADMA","created":"2026-06-12T11:00:06.446Z","tickers":["ADMA"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n12, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of its officers.\n(https://app.accessnewswire.com/imagelibrary/3a0d22a5-d2a9-48e7-9ee7-69e3d4693895/image.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired ADMA securities between August\n9, 2024 and March 25, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/ADMA.\n(https://bgandg.com/ADMA/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=ADMA)\n\nADMA Case Details\n\nThe Complaint alleges that throughout the Class Period, Defendants made false\nand/or misleading statements and/or failed to disclose that:\n1.\nADMA Biologics engaged in an undisclosed related party transaction;\n2.\nADMA Biologics used channel stuffing to create an appearance of revenue;\n3.\nADMA Biologics lacked adequate internal controls; and\n4.\nas a result, defendants' statements about ADMA Biologics' business,\noperations, and prospects were materially false and misleading and/or lacked a\nreasonable basis at all relevant times.\n\nWhat's Next for ADMA Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/ADMA.\n(https://bgandg.com/ADMA/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=ADMA)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in ADMA you have until August 10,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to ADMA Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for ADMA Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/adma-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1176125)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-06-12T11:00:06.711246623Z","server_sent_at_ms":1781262006711},"received_at":"2026-06-12T11:00:06.764Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/adma-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1176125"},"analysis":{"id":"51670","press_release_id":"62246","analysis_json":{"redFlags":[],"eventType":"legal_litigation","narrative":"Bronstein, Gewirtz & Grossman, LLC issued a shareholder-solicitation notice naming ADMA Biologics; no new disclosure from the company itself.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","sentiment":"neutral","keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"ADMA Biologics, Inc.","ticker":"ADMA"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bronstein, Gewirtz & Grossman, LLC. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"ADMA"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bronstein, Gewirtz & Grossman, LLC issued a shareholder-solicitation notice naming ADMA Biologics; no new disclosure from the company itself.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"ADMA Biologics, Inc.","ticker":"ADMA"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-12T11:06:49.488Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":14438,"modelName":"george-droid-qwen-72b"}}